![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/295 | (2006.01) |
A61K 31/295 | (2013.01) | ||
A61P 3/00 | (2006.01) | ||
A61P 7/06 | (2018.01) | ||
A61P 7/06 | (2006.01) | ||
A61P 13/12 | (2018.01) | ||
A61P 13/12 | (2006.01) | ||
A61K 9/28 | (2013.01) | ||
A61K 9/28 | (2006.01) |
(11) | Patento numeris | 3730136 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20163104.1 |
Europos patento paraiškos padavimo data | 2013-06-21 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-10-28 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-27 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
201261662565 P | 2012-06-21 | US | |
201361757229 P | 2013-01-28 | US | |
201361801050 P | 2013-03-15 | US | |
201361800618 P | 2013-03-15 | US |
(72) |
PORADOSU, Enrique , US
BENTSUR, Ron , US
OLIVIERO III, James F. , US
|
(73) |
Keryx Biopharmaceuticals, Inc. ,
245 First Street, Suite 1400, Cambridge, MA 02142,
US
|
(54) | USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS |
USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS |